Locations:
Search IconSearch

Neurosciences

19-NEU-3932-lewy-body_650x450
October 4, 2019/Geriatrics

Shedding Light on the Lewy Body Dementias (Podcast)

Neuro Pathways podcast delivers expert perspectives on a perplexing disorder

research
October 3, 2019/Cancer

Predicting Cancer Versus Autism Risk in Patients With PTEN Mutations

Biomarker may help individualize treatment

19-NEU-3974-online-conversations-650×450
October 2, 2019/Behavioral Health

Analysis of Online Conversations Gives Unique Glimpse Into Epilepsy-Suicide Links

Teens express fears and seek support but are less likely than adults to feel helpless

20-NEU-1922927-NeuroPathwayPodcast-social-Ads-CQD-650×450

Check Out Our Neuro Pathways Podcast

Keeping providers up to speed on a range of neurological topics

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-NEU-3979-relapsing-multiple-sclerosis-650×450
September 24, 2019/Neurosciences/Research

Phase 3 Ozanimod Trials Show Good Efficacy and Tolerability at 2 Years for Relapsing MS

Findings hint at potentially easier treatment initiation vs. other S1P receptor modulators

19-NEU-3931-sleep-brain-health-650×450

Sleep and Its Centrality to Brain Health (Podcast)

Neuro Pathways podcast episode shares emerging insights — plus tips for better sleep

19-NEU-3973-vaccineMS-grant-650×450
September 19, 2019/Neurosciences/News & Insights

AAN Updates Its Guideline on Vaccines in Multiple Sclerosis: What Providers Need to Know

Recommendations revisited in wake of a surge in disease-modifying therapies

650×450-Brain-Tumor2
September 19, 2019/Cancer/Research

Metabolic Reprogramming: A Promising Approach to Tackling Therapeutic Resistance in Glioblastoma

Targeting pyrimidine synthesis inhibits GSC self-renewal and tumorigenesis

19-NEU-3935-myelin-PET-650×450

New Myelin Imaging Strategy to Refine MS Diagnosis and Monitoring Garners $1.6M NIH Grant

Benefits of novel PET radiotracer expected to go beyond multiple sclerosis

19-NEU-3925-stereotactic-radiosurgery-brain-mets-650×450
September 16, 2019/Cancer

High-Dose Neoadjuvant Radiosurgery for Brain Metastases Appears Safe, Effective in Early Results from Phase 1/2 Study

Dose-escalation trial shows local control with low toxicity, low leptomeningeal recurrence

BackPage 52 of 113Next

Advertisement

Ad